Express Scripts and Prime Therapeutics Collaborate to Deliver More Affordable Care to More than 100 Million AmericansLearn More
1 Express Scripts grants a limited, non-transferable license to use the images and video content on this page (“Press Materials”) in connection with editorial usage by accredited members of the press, or other industry analysis reporting about Express Scripts. All other uses of the Press Materials are subject to prior written permission by Express Scripts. Press Materials may not be used for any personal or commercial use, or in any way that would be likely to create confusion as to whether Express Scripts is endorsing or sponsoring the usage. Press Materials may not be modified or changed in any way (other than with respect to photos, for resizing and with respect to video material, to accompany news reporting as indicated above). By downloading and otherwise using the Press Materials, you acknowledge and agree to these terms, and to all other applicable terms and conditions associated with this website.